ISSN 2639-9431
Vol. 8, Issue 4, 2025December 15, 2025 EDT
From BioMAG® to Feraheme®: Overview of the Intellectual Property History
From BioMAG® to Feraheme®: Overview of the Intellectual Property History
Articles in Vol. 8, Issue 4, 2025
Vol. 8, Issue 4, 2025
- Development and Characterization of Bromocriptine Mesylate Loaded Nanostructured Lipid Carriers for Enhanced Nose-to-Brain DeliveryDarshan KAAnita R DesaiMallappa ShalavadiBasavaraj S. NainegaliLaxman S Vijapur
- GIMAP and Lipid Metabolism Imaging in Clear Cell Renal Cell Carcinoma: A Negative Radiogenomic AnalysisFederico GrecoMarco CataldoAndrea PanunzioAlessandro TafuriBruno Beomonte ZobelCarlo Augusto Mallio
- A Validated Serum Biomarker Signature for the Non-Invasive Diagnosis of EndometriosisRusul F. AbediAhmed Jasim MohammedAbbas ChyadRedha Dawud Abd AlredhaGhanim A. AbbasKrarr Haider Haddawi
- Comparing CRISPR-Cas9 Gene Therapy Delivery Systems: Implications and Optimization for HyperargininemiaJad MadaniHumza N. ZubairGhazi A. SaroyaRachel E.N. ReyesRami Madani
- From BioMAG® to Feraheme®: Overview of the Intellectual Property HistoryErnest GromanDmitri Simberg
1.
Groman E, Simberg D. From BioMAG® to Feraheme®: Overview of the Intellectual Property History. Precis Nanomed. 2025;8(4):1673-1690. doi:10.33218/001c.154436